Article
Pharmacogenetics and interstitial lung disease.
Current opinion in pulmonary medicine - 1 Sept 2016
Oldham Justin M, Noth Imre, Martinez Fernando J
Abstract excerpt
PURPOSE OF REVIEW: Interstitial lung disease (ILD) is comprised of a heterogeneous group of disorders with highly variable natural histories and response to therapies. Pharmacogenetics focuses on the variability in drug response because of the presence of genetic factors that influence drug metabolism or disease activity. In this article, we review relevant drug-specific and disease-specific polymorphisms that...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
